Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Schlumberger
SLB
|
+$527M |
| 2 |
Qualcomm
QCOM
|
+$448M |
| 3 |
Marriott International Class A Common Stock
MAR
|
+$369M |
| 4 |
TIF
Tiffany & Co.
TIF
|
+$305M |
| 5 |
CELG
Celgene Corp
CELG
|
+$230M |
Top Sells
| 1 |
AGN
ALLERGAN INC
AGN
|
+$1.05B |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$543M |
| 3 |
Goldman Sachs
GS
|
+$496M |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$452M |
| 5 |
Estee Lauder
EL
|
+$329M |
Sector Composition
| 1 | Healthcare | 18.05% |
| 2 | Consumer Discretionary | 14.25% |
| 3 | Technology | 11.26% |
| 4 | Communication Services | 11.22% |
| 5 | Energy | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
AstraZeneca
AZN
$253B
| – | – |
-2,264,642
| Closed | -$73.5M |
|
702
Best Buy
BBY
$16.3B
| – | – |
-77,309
| Closed | -$2.04M |
|
703
Blackrock
BLK
$171B
| – | – |
-8,834
| Closed | -$2.78M |
|
704
Conagra Brands
CAG
$9.32B
| – | – |
-903,651
| Closed | -$21.8M |
|
705
Cimpress
CMPR
$1.54B
| – | – |
-6,180
| Closed | -$304K |
|
706
Corcept Therapeutics
CORT
$7.51B
| – | – |
-2,151,617
| Closed | -$9.38M |
|
707
Carpenter Technology
CRS
$12.3B
| – | – |
-6,649
| Closed | -$439K |
|
708
CSX Corp
CSX
$60.5B
| – | – |
-252,084
| Closed | -$2.43M |
|
709
Cytokinetics
CYTK
$6.23B
| – | – |
-250,000
| Closed | -$2.38M |
|
710
Donaldson
DCI
$9.47B
| – | – |
-7,100
| Closed | -$301K |
|
711
D.R. Horton
DHI
$54.9B
| – | – |
-17,910
| Closed | -$388K |
|
712
Danaher
DHR
$142B
| – | – |
-68,381
| Closed | -$3.45M |
|
713
Dick's Sporting Goods
DKS
$17.9B
| – | – |
-2,014,568
| Closed | -$110M |
|
|
714
Estee Lauder
EL
$32B
| – | – |
-4,923,791
| Closed | -$329M |
|
715
Enovis
ENOV
$1.79B
| – | – |
-6,909
| Closed | -$848K |
|
716
Exact Sciences
EXAS
$10.2B
| – | – |
-126,273
| Closed | -$1.79M |
|
717
FTI Consulting
FCN
$5.46B
| – | – |
-12,874
| Closed | -$429K |
|
718
Genpact
G
$7.71B
| – | – |
-18,234
| Closed | -$318K |
|
719
Green Dot
GDOT
$766M
| – | – |
-15,094
| Closed | -$295K |
|
720
The GEO Group
GEO
$2.93B
| – | – |
-2,068,596
| Closed | -$44.5M |
|
721
Hilton Worldwide
HLT
$65.3B
| – | – |
-114,743
| Closed | -$7.66M |
|
722
IBM
IBM
$239B
| – | – |
-19,996
| Closed | -$3.68M |
|
723
Inovio Pharmaceuticals
INO
$153M
| – | – |
-26,042
| Closed | -$4.16M |
|
724
IQVIA
IQV
$31.9B
| – | – |
-99,360
| Closed | -$5.05M |
|
725
iShares Russell 2000 ETF
IWM
$66.9B
| – | – |
0
| – | – |
|